This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: The State University of New York. Active years: 1995-2012.
Company Filing History:
Years Active: 1995-2012
Title: The Innovations of Robert M. Straubinger
Introduction
Robert M. Straubinger is a notable inventor based in Amherst, NY (US). He has made significant contributions to the field of therapeutic proteins, holding a total of 7 patents. His work focuses on enhancing the efficacy and safety of treatments for blood coagulation disorders.
Latest Patents
One of his latest patents is titled "Compositions and methods for less immunogenic protein-lipid complexes." This invention provides compositions and methods aimed at reducing the immunogenicity and increasing the circulating half-life of therapeutic proteins such as Factor VIII. The compositions include lipidic structures like liposomes, micelles, and cochleates that comprise a negatively charged lipid and polyethylene glycol derivatized phosphatidyl ethanolamine. Another significant patent is the "Method for treating blood coagulation disorders." This method involves administering compositions that contain lipidic particles made up of phosphatidylcholine, phosphatidylinositol, and cholesterol. These lipidic particles are associated with one or more peptides, polypeptides, or proteins involved in the blood coagulation cascade.
Career Highlights
Robert M. Straubinger is affiliated with The State University of New York, where he continues to advance research in his field. His innovative approaches have the potential to significantly impact the treatment of blood coagulation disorders.
Collaborations
He has collaborated with notable colleagues such as Karthik Ramani and Sathyamangalam V. Balasubramanian, contributing to a rich environment of research and development.
Conclusion
Robert M. Straubinger's work exemplifies the intersection of innovation and healthcare, particularly in the realm of blood coagulation treatments. His patents reflect a commitment to improving therapeutic outcomes for patients.